Holen Sie sich die Stockscreener-App
9.02
3.09%
0.27
Handel nachbörslich:
9.02
Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 80.00 |
Operating Expenses
|
2.88%
19.82
|
20.40 | 19.43 | 25.13 | 27.51 |
| Operating Income/Loss |
2.88%
-19.82
|
-20.40 | -19.43 | -25.13 | 52.49 |
| Income/Loss From Continuing Operations Before Tax |
2.03%
-17.30
|
-17.66 | -16.57 | -21.70 | 55.41 |
| Income/Loss From Continuing Operations After Tax |
2.03%
-17.30
|
-17.66 | -16.57 | -21.70 | 55.41 |
|
Net Income/Loss
|
2.03%
-17.30
|
-17.66 | -16.57 | -21.70 | 55.41 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.10%
62.54
|
62.48 | -62.14 | 62.41 | 62.20 |
| Diluted Average Shares |
0.10%
62.54
|
62.48 | -63.63 | 62.41 | 63.59 |
| Basic Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.27 | -0.35 | 0.89 |
| Diluted Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.27 | -0.35 | 0.87 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):